Thrombopoietin mimetics
US7648971B2 · kind B2 · utility
0Cited by
23References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 18, 2008 |
| Grant date | Jan 19, 2010 |
| Priority date | — |
| Expiry date | Jul 2, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.